Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
The effects of glucagon-like peptide 1 receptor agonist (exenatide) on memory impairment, and anxiety- and depression-like behavior induced by REM sleep deprivation
Store refrigerated 28C
Current antidiabetic medications aim at decreasing glucose levels, either by improving insulin secretion in the remaining -cells (using insulin secretagogues), by improving the response to insulin in target tissues (using insulin sensitizers), or by replacing the missing insulin (using exogenous insulin treatment)
Competitive Analysis: The report offers the appropriate analysis of the key organizations/companies involved within the North America glucagon-like peptide-1 (GLP-1) agonist market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis
A 2011 study of elite athletes losing weight at different rates found that those losing weight slowly (around 0.7% of body weight a week) gained 2.1% lean mass over the study
